Genfit Plunges After Liver Medicine Falls Short in Study

(Bloomberg) -- French biotech Genfit plunged after falling short in the race to develop a drug for a disease lurking undetected in tens of millions of people struggling with obesity and diabetes.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.